Showing results (81-90 of 581) with videos related to

Sort By:
Pageof 59
Future Oncology (London, England)|June 30, 2023
Clinical outcomes of intensive versus less intensive first-line chemotherapy for metastatic colorectal cancerKentaro Yamazaki, Satoshi Yuki, Eiji Oki, et al.
Anticancer Research|March 31, 2018
The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast CancerYuka Inoue, Nami Yamashita, Hiroki Ueo, et al.
International Journal of Clinical Oncology|July 20, 2006
Trastuzumab and breast cancer: developments and current statusEriko Tokunaga, Eiji Oki, Kojiro Nishida, et al.
Oncology|June 27, 2009
Phase II study of biweekly docetaxel and S-1 combination therapy for advanced or recurrent gastric cancerYoshihiro Kakeji, Eiji Oki, Akinori Egashira, et al.
The Journal of Biological Chemistry|July 5, 2002
p73beta is regulated by protein kinase Cdelta catalytic fragment generated in the apoptotic response to DNA damageJian Ren, Rakesh Datta, Hisashi Shioya, et al.
Anticancer Research|December 4, 2018
Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Patients with Esophageal Squamous Cell CarcinomaYuichiro Nakashima, Hiroshi Saeki, Qingjiang Hu, et al.
World Journal of Surgery|November 28, 2013
Significance of preoperative evaluation of the right gastroepiploic artery graft to the coronary artery in patients undergoing abdominal surgeryShuhei Ito, Shohei Yamaguchi, Hiroshi Saeki, et al.
Cancer Science|August 27, 2014
Molecular mechanisms regulating the hormone sensitivity of breast cancerEriko Tokunaga, Yuichi Hisamatsu, Kimihiro Tanaka, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 22, 2017
Clinical Outcomes of Esophagojejunostomy in Totally Laparoscopic Total Gastrectomy: A Multicenter StudyMasahiko Sugiyama, Eiji Oki, Kippei Ogaki, et al.
BMC Cancer|November 18, 2020
Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancerHironaga Satake, Koji Ando, Eiji Oki, et al.
Pageof 59